Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

458

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hematopoietic and Lymphoid Cell NeoplasmNon-Neoplastic Hematologic and Lymphocytic Disorder
Interventions
OTHER

Supportive Palliative Care

focuses on relieving symptoms of stress from serious illness and care through physical, cultural, psychological, social, spiritual, and ethical aspects

OTHER

Clinical Management

physical exercise, strength training, stress reduction, medication management, dietary recommendations, and education

OTHER

Best Practice

Given standard of care

PROCEDURE

Allogeneic Hematopoietic Stem Cell Transplantation

Undergo HCT

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Complete surveys

Trial Locations (11)

11042

Northwell Health Cancer Institute, New Hyde Park

37232

Vanderbilt University, Nashville

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

48201

Wayne State University/Karmanos Cancer Institute, Detroit

55455

University of Minnesota/Masonic Cancer Center, Minneapolis

55905

Mayo Clinic, Rochester

77030

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

94143

University of California San Francisco, San Francisco

94304

Stanford Cancer Institute Palo Alto, Palo Alto

97239

Oregon Health and Science University, Portland

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT03870750 - Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases | Biotech Hunter | Biotech Hunter